Is OKAVA testing GLP-1 drugs on pets?

Yes, OKAVA is conducting a pilot study on a GLP-1 drug for cats with obesity.

Will weight loss drugs for humans be used for cats?

A San Francisco company is exploring the use of GLP-1 drugs, known for human weight loss, for feline obesity.

What is the new frontier for GLP-1 drugs?

The new frontier for GLP-1 drugs appears to be in veterinary medicine, specifically for treating pet obesity.

Home / Health / Pet Obesity Drug Frenzy: Cats Next?

Pet Obesity Drug Frenzy: Cats Next?

7 Dec, 2025

•

Summary

Weight loss drug success in humans may extend to pets.
A biopharmaceutical company is studying a GLP-1 drug for cats.
Pilot study currently underway for feline obesity treatment.

The remarkable success of GLP-1 weight loss drugs among humans is now poised to enter the veterinary world. A San Francisco biopharmaceutical firm is spearheading this initiative, currently running a pilot study focused on a GLP-1 medication for cats struggling with obesity.

This pioneering research explores adapting human-centric treatments to address a widespread issue in pet health. The study aims to determine if these powerful drugs can offer a viable solution for feline weight management, mirroring their impact in human patients.

As the trend of pet obesity grows, this development offers a hopeful outlook for new therapeutic interventions. The results of this pilot study will be crucial in determining the future of GLP-1 drugs in veterinary care.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.